16 results on '"Lin, Zhuoyuan"'
Search Results
2. Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer
3. Aberrant Super-Enhancer Landscape in Enzalutamide-Resistant Prostate Cancer Cells
4. Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling
5. N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer
6. Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth
7. A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer
8. Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer
9. Perillaldehyde inhibits bone metastasis and receptor activator of nuclear factor-κB ligand (RANKL) signaling-induced osteoclastogenesis in prostate cancer cell lines
10. Abstract LB032: CXCR7 drives prostate cancer growth through AURKA activation
11. Perillaldehyde inhibits bone metastasis and receptor activator of nuclear factor-κB ligand (RANKL) signaling-induced osteoclastogenesis in prostate cancer cell lines
12. Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy
13. Elevated Levels of Mitochondrion-Associated Autophagy Inhibitor LRPPRC Are Associated With Poor Prognosis in Patients With Prostate Cancer
14. Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling
15. Arginase 2 is a Diagnostic and Prognostic Marker for Prostate Cancer and Is Associated with Metabolism.
16. Different therapeutic regimens in the treatment of metastatic prostate cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.